PDCD1 and prostate cancer: ESK981-mediated inhibition of autophagy-dependent cell death promoted C-X-C motif chemokine (CXCL10) secretion via the IFN-γ pathway and enhanced functional T cell infiltration, which conferred increased sensitivity to anti-PD-1 immunotherapy in preclinical models of prostate cancer.